Mutation analysis of the c-mos proto-oncogene in human ovarian teratomas
1998

Mutation Analysis of the c-mos Gene in Ovarian Teratomas

Sample size: 20 publication Evidence: low

Author Information

Author(s): KAF de Foy, SA Gayther, WH Colledge, S Crockett, IV Scott, MJ Evans, BAJ Ponder

Primary Institution: CRC Human Cancer Genetics Research Group, Addenbrooke's Hospital, Cambridge, UK

Hypothesis

Does the c-mos proto-oncogene have cancer-causing alterations in human ovarian teratomas?

Conclusion

Mutations in the coding region of the c-MOS gene do not play a significant role in the genesis of human ovarian teratomas.

Supporting Evidence

  • Female transgenic mice lacking c-mos develop ovarian teratomas, suggesting c-mos may act as a tumor-suppressor gene.
  • The study identified a previously reported polymorphism and a new silent variant in the c-MOS gene.
  • No disease-causing alterations were predicted from the identified variants.

Takeaway

The study looked at a gene called c-mos in tumors from 20 women and found that it doesn't cause these tumors.

Methodology

DNA from 20 ovarian teratomas was analyzed using single-strand conformational analysis and heteroduplex analysis, with sequencing performed on 9 samples.

Limitations

The study did not analyze genetic alterations outside the c-MOS coding region that might affect gene expression.

Participant Demographics

The study involved human ovarian teratomas, but specific demographic details of participants are not provided.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication